Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
CNS DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-28
DOI
10.1007/s40263-021-00815-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia
- (2020) George A. Keepers et al. AMERICAN JOURNAL OF PSYCHIATRY
- COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology
- (2019) Olaf M. Dekkers et al. PLOS MEDICINE
- Transitioning from oral risperidone or paliperidone to once-monthly paliperidone palmitate: a real-world analysis among Veterans Health Administration patients with schizophrenia who have had at least one prior hospitalization
- (2019) Antoine El Khoury et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations, Outcomes (REACH-OUT) study: real-world clinical practice in schizophrenia
- (2018) Kruti Joshi et al. BMC Psychiatry
- Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits
- (2018) Kruti Joshi et al. Journal of Comparative Effectiveness Research
- Adherence and economic impact of paliperidone palmitate versus oral atypical antipsychotics in a Medicare population
- (2018) Kruti Joshi et al. Journal of Comparative Effectiveness Research
- Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data
- (2018) Tingjian Yan et al. ADVANCES IN THERAPY
- Short-term rehospitalizations in young adults with schizophrenia treated with once-monthly paliperidone palmitate or oral atypical antipsychotics: a retrospective analysis
- (2018) Dominic Pilon et al. CURRENT MEDICAL RESEARCH AND OPINION
- A comparison of treatment patterns, healthcare resource utilization and costs among young adult Medicaid beneficiaries with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics in the U.S
- (2018) Janna Manjelievskaia et al. JOURNAL OF MEDICAL ECONOMICS
- Prescribing in schizophrenia and psychosis: Increasing polypharmacy over time
- (2017) Adrian Heald et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Indications for and use of long-acting injectable antipsychotics
- (2017) Taishiro Kishimoto et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies
- (2017) Taishiro Kishimoto et al. SCHIZOPHRENIA BULLETIN
- Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic
- (2017) Dominic Pilon et al. Patient Preference and Adherence
- Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychotics
- (2017) Dominic Pilon et al. JOURNAL OF MEDICAL ECONOMICS
- Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder
- (2017) Mallik Greene et al. JOURNAL OF MEDICAL ECONOMICS
- Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia
- (2016) Eduard Parellada et al. CNS DRUGS
- Comparison of Medicaid spending in schizoaffective patients treated with once monthly paliperidone palmitate or oral atypical antipsychotics
- (2016) Yongling Xiao et al. CURRENT MEDICAL RESEARCH AND OPINION
- Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans with Schizophrenia
- (2016) Yinong Young-Xu et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Economic Burden of Schizophrenia in the United States in 2013
- (2016) Martin Cloutier et al. JOURNAL OF CLINICAL PSYCHIATRY
- Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia
- (2016) Robert A. Rosenheck et al. PSYCHIATRIC SERVICES
- A pragmatic analysis comparing once-monthly paliperidone palmitate versus daily oral antipsychotic treatment in patients with schizophrenia
- (2016) Larry Alphs et al. SCHIZOPHRENIA RESEARCH
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychotics
- (2015) M.-H. Lafeuille et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia
- (2015) Georgia L. Stevens et al. Early Intervention in Psychiatry
- Towards a pragmatic and operational definition of relapse in schizophrenia: A Delphi consensus approach
- (2015) Luis San et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia
- (2015) Larry Alphs et al. JOURNAL OF CLINICAL PSYCHIATRY
- Expanding Therapy With Long-Acting Antipsychotic Medication in Patients With Schizophrenia
- (2015) William T. Carpenter et al. JAMA Psychiatry
- Impact of paliperidone palmitate versus oral atypical antipsychotics on healthcare outcomes in schizophrenia patients
- (2015) Yongling Xiao et al. Journal of Comparative Effectiveness Research
- Healthcare utilization and costs of veterans health administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics
- (2015) Onur Baser et al. JOURNAL OF MEDICAL ECONOMICS
- Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia
- (2014) Marie-Hélène Lafeuille et al. CURRENT MEDICAL RESEARCH AND OPINION
- The nature of relapse in schizophrenia
- (2013) Robin Emsley et al. BMC Psychiatry
- Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis
- (2013) Marie-Hélène Lafeuille et al. BMC Psychiatry
- Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia
- (2013) Taishiro Kishimoto et al. JOURNAL OF CLINICAL PSYCHIATRY
- Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia
- (2013) Gabriel Kaplan et al. Patient Preference and Adherence
- Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review
- (2013) José M Olivares et al. Annals of General Psychiatry
- Healthcare Cost Reductions Associated with the Use of LAI Formulations of Antipsychotic Medications Versus Oral Among Patients with Schizophrenia
- (2013) Jay Lin et al. JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH
- Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiation of treatment with long-acting injectable antipsychotics
- (2013) Rimal Bera et al. JOURNAL OF MEDICAL ECONOMICS
- Healthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oral
- (2012) Steve Offord et al. JOURNAL OF MEDICAL ECONOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started